No Picture
News

IASO Bio Announces NMPA’s IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma

SHANGHAI and NANJING, China and SAN JOSE, Calif., March 29, 2024 /PRNewswire/ — IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced that China […]

News

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF

Completed the reorganization of the Company during 2023 with all lab operations now located in the Sunnyvale, California Record revenue in 2023 of $1.2 million representing 43% growth over 2022 Record number of new collaborations […]

News

TEAMSTERS AT CENCORA/AMERISOURCEBERGEN RALLY FOR FAIR CONTRACT IN SACRAMENTO

Striking Warehouse Workers Demand Fair Pay, Improved Benefits SACRAMENTO, Calif., March 28, 2024 /PRNewswire/ — Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company’s Sacramento distribution center. The 124 […]

No Picture
News

AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights

MENLO PARK, Calif.–(BUSINESS WIRE)–AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter […]